AI-designed neoantigen vaccines just hit a Phase 3 milestone —
AI-designed neoantigen vaccines have reached a Phase 3 milestone, with the pipeline from tumor sequencing to mRNA construct increasingly driven by machine learning tools such as NetMHCpan, MHCflurry, …